What is Alibaba Health Information Technology EBITDA Margin %?
Alibaba Health Information TechnologyFRA:TWYA +0.83%83 EBITDA Margin % is 4.82% as of Mar. 2026, which is 213% above its 10-year median of 1.54. GuruFocus rates FRA:TWYA with a GF Score™ of 83/100 and a GF Value™ of €9.91 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 60.48% on this metric.
Alibaba Health Information Technology (FRA:TWYA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Alibaba Health Information Technology EBITDA Margin % Related Terms
Alibaba Health Information Technology EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology EBITDA Margin % Chart
Alibaba Health Information Technology EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology (FRA:TWYA) has a EBITDA Margin % of 4.82% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Alibaba Health Information Technology and its competitors. This is 213% above median its historical median of 1.54. According to the industry distribution chart, Alibaba Health Information Technology ranks #404 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 60.5%.
Is Alibaba Health Information Technology's EBITDA Margin % too high?
Alibaba Health Information Technology's current EBITDA Margin % of 4.82% is 213% above median its 10-year median of 1.54. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Alibaba Health Information Technology's value of 4.82% is 52.8% below this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #404 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alibaba Health Information Technology has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #404 out of 668 companies for EBITDA Margin %. This places Alibaba Health Information Technology in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Alibaba Health Information Technology's value of 4.82% is 52.8% below this benchmark. While the company's 10-year median is 1.54 vs. the industry median of 10.21, Alibaba Health Information Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current EBITDA Margin % of 4.82% is 52.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current EBITDA Margin % is 4.82%, which is 213% above median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (FRA:TWYA) is currently considered Significantly Undervalued. The stock's GF Value™ is €9.91, compared to a current price of €6.10 — trading 38.4% below its estimated fair value. The current EBITDA Margin % is 4.82%, which is 213% above median its 10-year median of 1.54 and 52.8% below the Healthcare Providers & Services industry median of 10.21. Alibaba Health Information Technology's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Alibaba Health Information Technology (FRA:TWYA), the current EBITDA Margin % is 4.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (FRA:TWYA) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of €6.10 is trading 38.4% below its estimated GF Value™ of €9.91.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for FRA:TWYA:
EBITDA Margin %: 4.82% (213% above median its 10-year median of 1.54)
GF Value™: €9.91 vs. price of €6.10 (38.4% below fair value)
Industry Position: 52.8% below the Healthcare Providers & Services median (#404 of 668)
No single metric tells the full story. See the FRA:TWYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
83GF Score
Get the complete analysis for FRA:TWYA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TWYA has been successfully added to your 
